Halozyme stock forecast
Halozyme (RV7) Stock Forecast & Price Target
RV7 Analyst Ratings
RV7 Stock 12 Month Forecast
Average Price Target
CHF96.48▼(-5.32% Downside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Sean Laaman | Morgan Stanley | CHF86.06→CHF89.34 | hold | -12.33%Downside | Downgraded | 11/10/26 | ||
| Mohit Bansal | Wells Fargo | CHF77.86→CHF90.16 | hold | -11.52%Downside | Assigned | 11/06/26 | ||
| Jason Butler | Citizens JMP | CHF76.23→CHF122.12 | buy | 19.84%Upside | Reiterated | 11/06/26 | ||
| Mitchell Kapoor | H.C. Wainwright | CHF106.55 | buy | 4.56%Upside | Reiterated | 11/06/26 | ||
| David Risinger | Leerink Partners | CHF90.16→CHF95.90 | hold | -5.89%Downside | Downgraded | 11/06/26 | ||
| Jessica Fye | J.P. Morgan | CHF63.93→CHF64.75 | hold | -36.46%Downside | Assigned | 11/03/26 | ||
| Brendan Smith | TD Cowen | CHF86.06→CHF106.55 | buy | 4.56%Upside | Assigned | 10/13/26 | ||
| Corinne Johnson | Goldman Sachs | CHF46.72 | sell | -54.15%Downside | Reiterated | 06/14/26 | ||
| Robert Wasserman | StoneX | CHF61.47→CHF73.77 | buy | -27.61%Downside | Reiterated | 02/19/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Sean LaamanMorgan Stanley | HoldDowngradedCHF86.06→CHF89.34 | 11/10/26 | -12.33%Downside | ||
| Mohit BansalWells Fargo | HoldAssignedCHF77.86→CHF90.16 | 11/06/26 | -11.52%Downside | ||
| Jason ButlerCitizens JMP | BuyReiteratedCHF76.23→CHF122.12 | 11/06/26 | 19.84%Upside | ||
| Mitchell KapoorH.C. Wainwright | BuyReiteratedCHF106.55 | 11/06/26 | 4.56%Upside | ||
| David RisingerLeerink Partners | HoldDowngradedCHF90.16→CHF95.90 | 11/06/26 | -5.89%Downside | ||
| Jessica FyeJ.P. Morgan | HoldAssignedCHF63.93→CHF64.75 | 11/03/26 | -36.46%Downside | ||
| Brendan SmithTD Cowen | BuyAssignedCHF86.06→CHF106.55 | 10/13/26 | 4.56%Upside | ||
| Corinne JohnsonGoldman Sachs | SellReiteratedCHF46.72 | 06/14/26 | -54.15%Downside | ||
| Robert WassermanStoneX | BuyReiteratedCHF61.47→CHF73.77 | 02/19/26 | -27.61%Downside |
Best Analysts Covering Halozyme
Copying Brendan Smith's trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +8.24% per trade.
Copying Brendan Smith's trades and holding each position for 1 Year would result in 95.00% of your transactions generating a profit, with an average return of +33.59% per trade.
Copying Brendan Smith's trades and holding each position for 2 Years would result in 95.00% of your transactions generating a profit, with an average return of +62.41% per trade.
RV7 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 7 | 9 | 8 | 12 | 9 |
| Hold | 3 | 2 | 1 | 2 | 5 |
| Sell | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 11 | 12 | 9 | 14 | 14 |
In the current month, RV7 has received 9 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. RV7 average Analyst price target in the past 3 months is 96.48.
RV7 Financial Forecast
RV7 Earnings Forecast
Next quarter’s earnings estimate for RV7 is CHF 2.12 with a range of CHF 1.78 to CHF 2.29. The previous quarter’s EPS was CHF 1.97. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
RV7 Sales Forecast
Next quarter’s sales forecast for RV7 is CHF 455.17M with a range of CHF 445.73M to CHF 474.06M. The previous quarter’s sales results were CHF 406.91M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
